Author:Julie Reid
Blogs
Rare diseases
Planning your EU orphan drug stock management with Sciensus
Blogs
Cancer
Personalised Vaccines and Cancer Treatment
Blogs
Rare diseases
Orphan drugs: How to avoid costly stock losses in Europe
Blogs
Rare diseases
How biotechs can expand in Europe: Pharmaceutical out-licensing vs. partnering
Blogs
Rare diseases
Compassionate use programmes in Europe: all you need to know
Blogs
Rare diseases
Lack of real-world data slowing your orphan drug’s success?
Thought Leadership
Rare diseases
Market access for orphan drugs in Switzerland: a guide for US Biotechs
Blogs
Rare diseases
An introduction to PASS studies
Events
Rare diseases
Sciensus hosts a panel at the World Orphan Drug Congress 2024